Innovation & The Bottom Line

As Blackstone Digital Infrastructure Trust preps its first earnings report, all eyes are on how the newly-listed REIT will deploy its capital in the red-hot data center market.

Mago Maga is launching its $1,598 Roma-X AI roaster on Kickstarter. Can its blend of smart tech and community features turn a niche hobby into the next big thing?

A company born from Celsius Mining's bankruptcy is skipping the IPO hype to directly list on Nasdaq, betting its massive power grid can solve AI's biggest bottleneck.

Aptyx's appointment of CFO David Price as CEO signals a classic private equity playbook: leveraging financial discipline to drive aggressive growth in medtech.

As firms rush to deploy AI, the risk of catastrophic failure looms. A new certifiable standard, ISO/IEC 42001, offers a lifeline. Here's what it means.

At Farnborough, Volatus Aerospace showcases its SKYDRA™ C-UAS platform, spearheading Canada's push into the booming global drone defense market.

Cypriot banktech Xryma Plc is listing on Euronext Paris without raising a cent. We explore the strategy behind this unconventional move and its deep infrastructure play.

Yellowstone Bourbon’s 2026 release blends 14-year-old bourbon with a dual-port cask finish, targeting collectors and conscious consumers alike.

With the hire of COO Ainslie Little, Flagship-backed ProFound Therapeutics signals a strategic shift from pure discovery to operational scale-up.

A UK software firm and a semiconductor giant just commercialized a GPS fix for cars. It's a simple upgrade that solves one of autonomous driving's hardest problems.

Liquid Instruments' GenInst Studio uses AI to build custom test gear from text prompts, slashing R&D time from months to minutes and challenging industry giants.

Tether's strategic investment in Pact Labs aims to put a new digital dollar, USA₮, in every paycheck. But can this fintech revolution overcome deep-seated regulatory and technical hurdles?

A small biotech is raising millions with a high-risk funding plan to launch a BOTOX alternative. Can it survive long enough to disrupt a pharma titan?

Legal tech leader Filevine is integrating a VC-backed AI that cuts medical record retrieval from months to days. This could be a game-changer for law firm profits.

As Alberta opens its billion-dollar iGaming market, global giant bet365 joins a crowded field. Can its unique features and CFL pact conquer the West?

Alto Neuroscience's $100M raise fuels its quest to treat resistant depression. It's a high-stakes play on a biomarker-driven approach in a challenging field.

Chesapeake Utilities is doubling down on the Sunshine State with a massive natural gas pipeline. But is this $1.2 billion project a masterstroke or a risky gamble?

A strategic partnership between FHLB Dallas and community banks is turning the tide on housing affordability, using targeted grants to create new homeowners and generational wealth.

As Primis Financial schedules its Q2 earnings call, investors are watching closely. Can its hybrid digital-physical model sustain momentum amid industry headwinds?

As the peptide therapy market surges, one app is ditching subscriptions and ads. We analyze Peptide Tracker's risky 'free-forever' strategy.